Survival Benefit Seen With Triple Therapy for Severe COVID-19
Compared with dual therapy, significant survival benefit seen with dexamethasone, remdesivir, and baricitinib but no change in length of stay
Few Insured Individuals Receive Timely DAA Treatment for Hep C
Individuals with Medicare and Medicaid have lower odds of treatment initiation than those with private insurance
Increase in Pediatric Intracranial Abscess Cases Seen During COVID-19
Increases seen in isolated intracranial abscess and sinusitis complicated by intracranial abscess during early COVID-19 pandemic
FDA Stretches Monkeypox Vaccine Supply by Authorizing Smaller Doses
New vaccine regimen will be given intradermally and at one-fifth the usual dose
Most Older Americans Say They Will Get Updated COVID-19 Booster in Fall
Poll suggests ~61 percent of people older than 50 years who have gotten at least one dose of vaccine say they would get an updated booster
SARS-CoV-2 Infection Not Linked to T1DM-Related Autoimmunity
No significant association seen with presence of multiple islet autoantibodies, single high-affinity islet autoantibodies in children, teens
HTN Linked to Hospitalization for Omicron in Vaccinated Persons
Findings seen among individuals who received at least three mRNA vaccine doses, subsequently diagnosed with COVID-19 during omicron surge
Most Patients Regain Taste, Smell Following COVID-19
However, roughly 10 percent of pre-omicron COVID-19 patients report recovery took more than six months
Poll: Inflation Has Many Americans Cutting Back on Health Care
One in four Americans have put off medical care or prescription purchases due to higher prices
Hep C Reinfection Low Among People Receiving Opioid Agonist Therapy
Rate of hepatitis C virus reinfection higher among people with recent injecting drug use
